Dosimertinib-d5 mesylate |
Catalog No.GC69000 |
Dosimertinib-d5 (mesylate) is an effective orally active EGFR inhibitor. It reduces the expression of p-EGFR and p-ERK proteins. Dosimertinib-d5 (mesylate) exhibits anti-proliferative and anti-tumor activity. Dosimertinib-d5 (mesylate) has potential for research in non-small cell lung cancer (NSCLC).
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
Review for Dosimertinib-d5 mesylate
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Dosimertinib-d5 mesylate
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *